| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259315C Antagonists of MCP-1 function and methods of use thereof |
| 06/14/2006 | CN1259314C Hydrophilipolymer and flavone combined object and medicinal composition containing said combined object |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/14/2006 | CN1259107C Composition of half solid framework preparation of ginkgo leaf extract product |
| 06/14/2006 | CN1259098C Exterior-applied Chinese herbal medicine preparation for traumatic infection and inflammation-relieving acesodyne and its preparation method |
| 06/14/2006 | CN1259087C Medicine for treating trauma and sores and its preparing process |
| 06/14/2006 | CN1259085C Sapid invigorating yang capsule and the preparation thereof |
| 06/14/2006 | CN1259075C Chinese traditional medicinal composition for replenishing qi, invigorating spleen, calming heart and tranquilizing mind |
| 06/14/2006 | CN1259070C Health capsule with auxiliary protective function for chemical liver damage and its preparing method |
| 06/14/2006 | CN1259068C Dogwood extraction and its preparation method and usage |
| 06/14/2006 | CN1259062C External use medicine for treating facial paralysis peripherica and its prepn |
| 06/14/2006 | CN1259058C Medicinal composition for treating liver disease, its preparation method and use |
| 06/14/2006 | CN1259057C Pharmaceutical composition containing ginkgo leaf poly pentenol and its preparing method |
| 06/14/2006 | CN1259056C Use of adenosine A3 receptor agonist for inhibition of viral replication |
| 06/14/2006 | CN1259055C Method for preparing azithromycin superfine powder by ultrasound emulsion dissolvent diffusion method |
| 06/14/2006 | CN1259054C Application of gentiopicrin in preparing medication for restraining hepatitis B virus |
| 06/14/2006 | CN1259053C Medicinal preparation containing erythromycine ethylsuccinate |
| 06/14/2006 | CN1259052C Medicinal composition for treating burn and scald and preparing method |
| 06/14/2006 | CN1259051C Medicines and medicinal kits |
| 06/14/2006 | CN1259050C Oral formulation of hydroxycamptothecin and its preparation method |
| 06/14/2006 | CN1259049C Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 06/14/2006 | CN1259048C Novel use of biphenyldicarboxylate as tumour multi-drug resistance inversion agent |
| 06/14/2006 | CN1259047C Kudzu vine flavone capsule, and its prepn. method |
| 06/14/2006 | CN1259046C Soyisoflavone soft capsule and its preparation technology |
| 06/14/2006 | CN1259045C Use of sinapine in preparing medicine for preventing and curing senile dementia |
| 06/14/2006 | CN1259044C Bone metabolism improving agents |
| 06/14/2006 | CN1259043C Application of salvia acid in pharmacy |
| 06/14/2006 | CN1259042C Calcium phenol sulfonate dispersive tablets and their preparation |
| 06/14/2006 | CN1259041C Bromhexine Hydrochloride aseptic freeze-drying formulation for injection and its preparation method |
| 06/14/2006 | CN1259040C Albuterol time controlling pulse slow release oral preparation and its preparation method |
| 06/14/2006 | CN1259036C Breviscapine drop pills and preparing method |
| 06/13/2006 | USRE39132 Thiazoline acid derivatives |
| 06/13/2006 | USRE39131 Heterocyclic compounds |
| 06/13/2006 | USRE39130 iNSECTICIDES; CONTAINING A 2-CYANOIMINO GROUP ON HETEROCYCLIC RING |
| 06/13/2006 | USRE39129 Insecticides; containing a 2-cyanoimino group attached to heterocyclic ring |
| 06/13/2006 | USRE39128 Antibacteria drug; respiratory system disorders; otitis |
| 06/13/2006 | USRE39127 Heterocyclic compounds |
| 06/13/2006 | US7060871 Use of exogenous β-adrenergic receptor and β-adrenergic receptor kinase gene constructs to enhance myocardial function |
| 06/13/2006 | US7060856 Kinase inhibitors; dissolving in water, alcohol mixture; cooling; solvent extraction |
| 06/13/2006 | US7060845 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060834 Using a 2-aminoquinoline compound |
| 06/13/2006 | US7060833 Reacting 6-hydroxy-3,4-dihydroquinoline with 1-cyclohexyl-5-(halbutyl)tetrazole in presence of a base |
| 06/13/2006 | US7060832 Nitrogen-containing fused heterocyclic carboxylic acids having an absolute configuration of “R” |
| 06/13/2006 | US7060828 Angiogenosis inhibitor; anticancer agents |
| 06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
| 06/13/2006 | US7060826 Central nervous system disorders; Alzheimer's disease; huntington's disease; Parkinson's disease; attention deficit disorders; schizophrenia; Tourette's syndrome |
| 06/13/2006 | US7060824 Pyrrolotriazolopyrimidinone derivatives |
| 06/13/2006 | US7060823 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 06/13/2006 | US7060809 Locked nucleic acid units may be used in a wide variety of applications, such as PCR primers, sequencing, synthesis of antisense oligonucleotides, diagnostics and the like |
| 06/13/2006 | US7060733 Methods for treating pancreatitis with curcumin compounds and inhibitors of reactive oxygen species |
| 06/13/2006 | US7060732 Antiacne; skin disorders; packaged separately |
| 06/13/2006 | US7060731 Such as meglumine, 3-methylamino-1,2 propandiol or 2-(methylamino)-ethanol as complement inhibitors, to combact activation of the kinin/kallikrein system or as an anticoagulant |
| 06/13/2006 | US7060730 Rapidly absorbed liquid compositions |
| 06/13/2006 | US7060729 Composition and method for treating skin |
| 06/13/2006 | US7060728 for the treatment of dry eye and other disorders requiring the wetting of the eye, including symptoms of dry eye associated with refractive surgery such as LASIK surgery |
| 06/13/2006 | US7060727 Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof |
| 06/13/2006 | US7060726 Antibacterial agent |
| 06/13/2006 | US7060725 Substituted sulfamate anticonvulsant derivatives |
| 06/13/2006 | US7060724 Water soluble paclitaxel derivatives |
| 06/13/2006 | US7060723 Administering sodium channel moderator; antiepileptic agents |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | US7060721 Phosphodiesterase inhibitor; antidiabetic agents; atherosclerosis; cardiovascular disorders; polyctstic ovary syndrome; hypotensive agents; hyperglycemic agents |
| 06/13/2006 | US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions |
| 06/13/2006 | US7060719 Glutaminyl based DPIV inhibitors |
| 06/13/2006 | US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
| 06/13/2006 | US7060717 Phosphodiesterase inhibitor; antiinflammatory agents; antiallergens; respiratory system disorders; wound healing agents |
| 06/13/2006 | US7060716 Compound containing two triple bonds |
| 06/13/2006 | US7060715 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 06/13/2006 | US7060713 Substituted piperidines |
| 06/13/2006 | US7060712 Crystalline form of aryl aniline β2 adrenergic receptor agonist |
| 06/13/2006 | US7060711 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist |
| 06/13/2006 | US7060710 Isoxazole pyrazoloindane derivatives as cognition enhancing GABAA α5 subtype ligands |
| 06/13/2006 | US7060709 Method of treating hepatic fibrosis |
| 06/13/2006 | US7060707 Isoquinoline derivatives |
| 06/13/2006 | US7060706 Quinazolinones |
| 06/13/2006 | US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma |
| 06/13/2006 | US7060704 S-aminoalkylsulfonamides, e.g., 3-[4-(3-Chlorophenyl)piperazin-1-yl]propylsulfonyl-2,3-dihydro-1H-indole, used to lower IOP, improvi blood flow to the optic nerve head and the retina, provide neuroprotection, and treat retinal diseases, sleep disorders, depression, and other psychiatric disorders |
| 06/13/2006 | US7060703 Indolinone derivatives |
| 06/13/2006 | US7060702 Chemical compounds |
| 06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 06/13/2006 | US7060698 5-alkylaminocarbonyl-substituted, e.g., 4-(1-benzyl-piperidin-4-yl)-2-isopropyl-3-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepine-5-carboxylic acid tert-butylamide; gamma -secretase inhibitors for the treatment of Alzheimer's disease. |
| 06/13/2006 | US7060697 Immunosuppressant compounds and compositions |
| 06/13/2006 | US7060696 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions |
| 06/13/2006 | US7060695 Providing, at a frequency of at least about every 45 days during at least a period of three months following an initial photodynamic therapy (PDT), additional PDT treatments to subject after evaluations for neovascular leakage |
| 06/13/2006 | US7060694 High potency dihydroergotamine compositions |
| 06/13/2006 | US7060693 containing at least one ecdysteroid and at least one iridoid is used for hydration of the basal layers of the epidermis of a person having a deficiency in regulation of the water fluxes or having a deficiency in the functionality of aquaporins AQP3 |
| 06/13/2006 | US7060692 Synergistic mixture; insecticides, miticides |
| 06/13/2006 | US7060691 Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases |
| 06/13/2006 | US7060689 Methods and compositions for delivery and retention of active agents to lymph nodes |
| 06/13/2006 | US7060686 treating, preventing, or inhibiting disorders associated with inflammation, cell-proliferation, and pain by administering a pseudopterosin, a seco-pseudopterosin, a diterpene aglycone, or a tricyclic diterpene |
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060504 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity |
| 06/13/2006 | US7060498 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 06/13/2006 | US7060470 Isoflavone-β-D-glucan produced by Agaricus blazei in the submerged liquid culture and method of producing same |
| 06/13/2006 | US7060466 Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene |
| 06/13/2006 | US7060449 Method of preparing GALR2 receptors composition |